Linedata Services S.A. (LIN)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 46.00 |
|---|---|
| 52-week range | 37.30 – 54.80 |
| Return, 1 month / 3 months | −14.8% / −3.0% |
| Return, 1 year / 3 years | −5.9% / −2.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 33 |
| Volatility (1 year) | 30.7% |
| Worst drawdown (1 year) | -20.5% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Linedata Services is a software and services company that serves the financial industry. It supplies platforms for asset management, fund administration, lending and credit, and insurance, helping institutions run portfolio management, trading, compliance and back-office operations. Its customers include investment managers, fund administrators, lenders and insurers, and the company is based in France while serving clients in many countries.
On this site Linedata Services S.A. appears as a stock on the Euronext Paris (France), code LIN, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Linedata Services S.A. (LIN) trades on the Euronext Paris in France. It last closed at EUR 46.00 on 23 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 103 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.9% and over the last three months it fell 3.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.2% | ||
| From 52-week high | -15.4% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -3.0% | ||
| 6-month return | 5.5% | ||
| 12-month return, skipping the last month | 10.5% | ||
| Stability (higher is calmer) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.5% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.2% |
|---|---|
| 1 month | −14.8% |
| 3 months | −3.0% |
| 6 months | +5.5% |
| 1 year | −5.9% |
| 3 years | −2.9% |
| 5 years | +34.9% |
Signals
| 50-day / 200-day average | 48.17 / 42.93 |
|---|---|
| Golden / death cross (60 days) | Golden, 58 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.19 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Jul 2026 | EUR 1.2000 |
| 8 Jul 2025 | EUR 1.7500 |
| 8 Jul 2024 | EUR 1.7500 |
| 5 Jul 2023 | EUR 1.7500 |
| 6 Jul 2022 | EUR 1.6000 |
| 6 Jul 2021 | EUR 1.3500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.